Novel biomarker tests have met or exceeded the performance of common lab tests for diagnosing nonalcoholic steatohepatitis (NASH, now known as metabolic dysfunction-associated steatohepatitis or MASH) ...

A liver biopsy is an outpatient procedure that your doctor may recommend to diagnose an underlying medical condition. The procedure may cause pain, but it’s usually short lasting. Many liver biopsies ...

The popularity of noninvasive options to diagnose liver disease has been growing, but are there times when more traditional methods like liver biopsy are still needed for a precise diagnosis? Medical ...

An AI-powered blood test that analyzes DNA fragments could detect silent liver disease long before symptoms begin.

Researchers have created a liquid biopsy test, which uses two circulating proteins, to test for major liver diseases. The test was found to be highly accurate, sensitive, and specific for both NASH ...

Please provide your email address to receive an email when new articles are posted on . In a multicenter study, researchers identified two novel protein biomarkers (PLIN2 and RAB14) that demonstrated ...

Please provide your email address to receive an email when new articles are posted on . Agile scores had the highest predictive value and classified fewer patients in the intermediate-risk group vs.

Fatty liver disease happens when too much fat builds up in the liver. Metabolic dysfunction-associated steatohepatitis (MASH) is a severe type of fatty liver disease where fat buildup causes liver ...